These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 14656481)
1. MIS/AMH in the assessment of cryptorchidism and intersex conditions. Lee MM; Misra M; Donahoe PK; MacLaughlin DT Mol Cell Endocrinol; 2003 Dec; 211(1-2):91-8. PubMed ID: 14656481 [TBL] [Abstract][Full Text] [Related]
2. Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism. Misra M; MacLaughlin DT; Donahoe PK; Lee MM J Clin Endocrinol Metab; 2002 Aug; 87(8):3598-602. PubMed ID: 12161481 [TBL] [Abstract][Full Text] [Related]
3. The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization. Misra M; MacLaughlin DT; Donahoe PK; Lee MM J Clin Endocrinol Metab; 2003 Feb; 88(2):787-92. PubMed ID: 12574214 [TBL] [Abstract][Full Text] [Related]
4. Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities. Gustafson ML; Lee MM; Asmundson L; MacLaughlin DT; Donahoe PK J Pediatr Surg; 1993 Mar; 28(3):439-44. PubMed ID: 8468660 [TBL] [Abstract][Full Text] [Related]
5. [Anti-Müllerian hormone (AMH) measurements in the assessment of testicular function in prepubertal boys and in sexual differentiation disorders]. Szarras-Czapnik M; Gajewska M; Ksiazyk J; Janas R; Ginalska-Malinowska M Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):195-9. PubMed ID: 17020655 [TBL] [Abstract][Full Text] [Related]
6. Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. Lee MM; Donahoe PK; Silverman BL; Hasegawa T; Hasegawa Y; Gustafson ML; Chang YC; MacLaughlin DT N Engl J Med; 1997 May; 336(21):1480-6. PubMed ID: 9154766 [TBL] [Abstract][Full Text] [Related]
7. Paediatric applications of anti-müllerian hormone research. 1992 Andrea Prader Lecture. Josso N Horm Res; 1995; 43(6):243-8. PubMed ID: 7607609 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. Rey RA; Belville C; Nihoul-Fékété C; Michel-Calemard L; Forest MG; Lahlou N; Jaubert F; Mowszowicz I; David M; Saka N; Bouvattier C; Bertrand AM; Lecointre C; Soskin S; Cabrol S; Crosnier H; Léger J; Lortat-Jacob S; Nicolino M; Rabl W; Toledo SP; Baş F; Gompel A; Czernichow P; Josso N J Clin Endocrinol Metab; 1999 Feb; 84(2):627-31. PubMed ID: 10022428 [TBL] [Abstract][Full Text] [Related]
9. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. Lee MM; Donahoe PK; Hasegawa T; Silverman B; Crist GB; Best S; Hasegawa Y; Noto RA; Schoenfeld D; MacLaughlin DT J Clin Endocrinol Metab; 1996 Feb; 81(2):571-6. PubMed ID: 8636269 [TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Guibourdenche J; Lucidarme N; Chevenne D; Rigal O; Nicolas M; Luton D; Léger J; Porquet D; Noël M Mol Cell Endocrinol; 2003 Dec; 211(1-2):55-63. PubMed ID: 14656477 [TBL] [Abstract][Full Text] [Related]
11. Serum levels of Mullerian inhibiting substance in boys with cryptorchidism. Yamanaka J; Baker M; Metcalfe S; Hutson JM J Pediatr Surg; 1991 May; 26(5):621-3. PubMed ID: 1676417 [TBL] [Abstract][Full Text] [Related]
12. How to evaluate gonadal function in the cryptorchid boy. Lessons from new testicular markers. Rey R J Pediatr Endocrinol Metab; 2003 Mar; 16(3):357-64. PubMed ID: 12705358 [TBL] [Abstract][Full Text] [Related]
13. [Antimullerian hormone in clinical human applications]. Josso N; Rey R Contracept Fertil Sex; 1994 Oct; 22(10):661-3. PubMed ID: 7804385 [TBL] [Abstract][Full Text] [Related]
14. Testicular dysgenesis does not affect expression of anti-müllerian hormone by Sertoli cells in premeiotic seminiferous tubules. Rey R; al-Attar L; Louis F; Jaubert F; Barbet P; Nihoul-Fékété C; Chaussain JL; Josso N Am J Pathol; 1996 May; 148(5):1689-98. PubMed ID: 8623936 [TBL] [Abstract][Full Text] [Related]
15. Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. Rajpert-De Meyts E; Jørgensen N; Graem N; Müller J; Cate RL; Skakkebaek NE J Clin Endocrinol Metab; 1999 Oct; 84(10):3836-44. PubMed ID: 10523039 [TBL] [Abstract][Full Text] [Related]
17. The persistent Müllerian duct syndrome: a molecular approach. Guerrier D; Tran D; Vanderwinden JM; Hideux S; Van Outryve L; Legeai L; Bouchard M; Van Vliet G; De Laet MH; Picard JY J Clin Endocrinol Metab; 1989 Jan; 68(1):46-52. PubMed ID: 2562843 [TBL] [Abstract][Full Text] [Related]
18. The concordance between serum anti-Mullerian hormone and testosterone concentrations depends on duration of hCG stimulation in boys undergoing investigation of gonadal function. Ahmed SF; Keir L; McNeilly J; Galloway P; O'Toole S; Wallace AM Clin Endocrinol (Oxf); 2010 Jun; 72(6):814-9. PubMed ID: 19811508 [TBL] [Abstract][Full Text] [Related]
19. Mullerian inhibiting substance: a gonadal hormone with multiple functions. Lee MM; Donahoe PK Endocr Rev; 1993 Apr; 14(2):152-64. PubMed ID: 8325249 [TBL] [Abstract][Full Text] [Related]
20. An enzyme linked immunoassay for anti-müllerian hormone: a new tool for the evaluation of testicular function in infants and children. Josso N; Legeai L; Forest MG; Chaussain JL; Brauner R J Clin Endocrinol Metab; 1990 Jan; 70(1):23-7. PubMed ID: 1688440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]